General Information of Binding Target of SBP (BTS) (ID: ST00012)
BTS Name
T-cell surface glycoprotein CD3 epsilon chain
Synonyms
T-cell surface antigen T3/Leu-4 epsilon chain; CD antigen CD3e
BTS Type
Protein
Gene Name
CD3E
Organism
Homo sapiens (Human)
Function
Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinases LCK and FYN, resulting in the activation of downstream signaling pathways In addition of this role of signal transduction in T-cell activation, CD3E plays an essential role in correct T-cell development. Initiates the TCR-CD3 complex assembly by forming the two heterodimers CD3D/CD3E and CD3G/CD3E. Participates also in internalization and cell surface down-regulation of TCR-CD3 complexes via endocytosis sequences present in CD3E cytosolic region
UniProt ID
P07766
UniProt Entry
CD3E_HUMAN
PFam
PF02189
Gene ID
916
Sequence
MQSGTHWRVLGLCLLSVGVWGQDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQ
HNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCE
NCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERP
PPVPNPDYEPIRKGQRDLYSGLNQRRI
Sequence Length
207
Synthetic Binding Protein (SBP) Targeting This BTS
SBP Name Highest Status Mechanism Affinity Application Details Ref
Abl/Hck SH3 domain anti-CD3E Epsilon1 Research Binder N.A. Tools for versatile retargeting of SH3 domain binding
SBP Info
[1]
Abl/Hck SH3 domain anti-CD3E Epsilon2 Research Binder N.A. Tools for versatile retargeting of SH3 domain binding
SBP Info
[1]
Abl/Hck SH3 domain anti-CD3E Epsilon3 Research Binder N.A. Tools for versatile retargeting of SH3 domain binding
SBP Info
[1]
Affimer anti-CD3/CD3E AVA-002 Research Binder N.A. Cancers [ICD-11: 2D4Z]
SBP Info
[2]
BiTE anti-CD38/CD3E Research Activator N.A. Multiple myeloma [ICD-11: 2A83.Y]
SBP Info
[3]
scFv Emerfetamab Phase I Binder N.A. Acute myeloid leukaemia [ICD-11: XH8AA5]
SBP Info
[4]
VNAR anti-EpCAM/CD3E B1 Research Binder Kd: 422 nM Research tool
SBP Info
[5]
References
1 Versatile retargeting of SH3 domain binding by modification of non-conserved loop residues. FEBS Lett. 2007 May 1;581(9):1735-41.
2 Avacta. Product Development Pipeline. 2021.
3 Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma. Haematologica. 2021 Apr 1;106(4):1193-1197.
4 Therapeutic Structural Antibody Database. Emerfetamab
5 The Shark Strikes Twice: Hypervariable Loop 2 of Shark IgNAR Antibody Variable Domains and Its Potential to Function as an Autonomous Paratope. Mar Biotechnol (NY). 2015 Aug;17(4):386-92.